SCHEMBL13699062

SCHEMBL13699062

CCCc1cc(C#N)ccc1OCCCOc1ccc2c(ccn2CC(=O)OC)c1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 18/20 0.57
PPARA Q07869 17/20 0.57
PPARD Q03181 15/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4228991 0.91 PPARG (0.69) PPARGPPARAPPARD
SCHEMBL12568368 0.85 PPARG (0.63) PPARGPPARAPPARD
SCHEMBL12568367 0.85 PPARG (0.58) PPARGPPARAPPARD
SCHEMBL12621106 0.85 PPARG (0.51) PPARGPPARAPPARD
SCHEMBL2001979 0.81 PPARA (0.52) PPARGPPARAPPARD
SCHEMBL12568369 0.79 PPARA (0.57) PPARGPPARAPPARD
SCHEMBL8029435 0.78 ATM (0.53)
SCHEMBL12568378 0.77 PPARA (0.59) PPARGPPARAPPARD
SCHEMBL4223705 0.76 PPARG (0.75) PPARGPPARAPPARD
SCHEMBL2001889 0.74 PPARD (0.51) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592361-B2 (5-{3-[4-(4,5,6,7-tetrahydro-benzooxazol-2-yl)-phenoxy]-propoxy}-indol-1-yl)-acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic disease BAYER PHARMACEUTICALS CORPORATION (US) 2009-09-22 US disclosed